NDC 13925-522 – Pentamidine Isethionate
Pentamidine Isethionate 300 mg/300mg · Inhalant · Respiratory (inhalation)
Product NDC13925-522
Product details
- Brand name
- Pentamidine Isethionate
- Generic name
- Pentamidine Isethionate
- Labeler
- Seton Pharmaceuticals
- Dosage form
- Inhalant
- Route
- Respiratory (inhalation)
- Marketing category
- ANDA · ANDA206667
- Marketed since
- October 14, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antiprotozoal
Active ingredients
- Pentamidine Isethionate 300 mg/300mg
Uses, dosage, side effects and warnings for Pentamidine Isethionate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 13925-522-01 | 1 VIAL in 1 CARTON (13925-522-01) / 300 mg in 1 VIAL | Oct 14, 2019 |
Other Pentamidine Isethionate products
- 0121-1102 Pentamidine Diisethionate 300 mg/300mg · Inhalant · PAI Holdings, LLC dba PAI Pharma
- 39822-3030 Pentamidine Isethionate 300 mg/6mL · Inhalant · XGen Pharmaceuticals DJB, Inc.
- 23155-748 Pentamidine Isethionate 300 mg/300mg · Injection, Powder, Lyophilized, For Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 0121-1101 Pentamidine Diisethionate 300 mg/300mg · Injection, Powder, Lyophilized, For Solution · PAI Holdings, LLC dba PAI Pharma
- 13925-515 Pentamidine Isethionate 300 mg/300mg · Injection, Powder, Lyophilized, For Solution · Seton Pharmaceuticals
- 39822-3050 Pentamidine Isethionate 300 mg/3mL · Injection, Powder, Lyophilized, For Solution · XGen Pharmaceuticals DJB, Inc.